News | Flat Panel Displays | February 28, 2017

Barco Introduces Nio Color 5MP Display for General Radiology and Mammography

Company’s color calibration technology ensures consistency in color for higher-quality images

February 28, 2017 — Healthcare imaging specialist Barco recently introduced the Nio Color 5MP diagnostic color display with a 5.8 megapixel resolution, making it suitable for general radiology as well as breast imaging, including breast tomosynthesis. It comes with Barco’s unique color calibration technology for consistent images, whether in color or in grayscale, to ensure the accuracy of the display and to support confident diagnostic decisions.

Many radiologists will order supplementary imaging exams to see additional detail and get a more holistic view of a patient’s condition. It is why color imaging is more and more important and why the consistency of color images matters.

The Nio Color 5MP has been designed especially for demanding radiology applications that require excellent grayscale rendition and detail, especially appreciated in mammography and breast tomosynthesis. In addition, it includes sophisticated calibrated color that also improves gray images, a feature previously only available on Barco’s Coronis Uniti display system.

With its 5.8 megapixel resolution, the new Nio offers more pixels than traditional mammography displays, according to Barco, so you can see more of the image. Its aspect ratio is a perfect fit for tall X-ray images — especially for the MLO view in mammography — resulting in less panning and zooming for a better reading experience. It also comes with Barco’s SpotView technology to get a closer look at a particular region of interest.

Just like the DICOM standard ensures consistent grayscales across displays, color images need additional monitoring, correction and calibration too in order to render them in a meaningful way. That is why Barco developed its SteadyColor technology to ensure consistency in color, from display to display, so radiologists can make a diagnosis based on reliable images.

Barco’s sensor technology, combined with MediCal QAWeb for automated calibration and quality assurance (QA), makes sure every image is displayed to perfection in a highly regulated environment. With MediCal QAWeb, compliance with Mammography Quality Standards Act (MQSA) and QA guidelines is effortless.

Like most of Barco’s medical displays, Nio Color 5MP comes with a set of tools to help radiologists work smarter, not harder. These include features for dimming of auxiliary displays, enhancing visualization of details, and personalizing display settings, such as Clearbase or BlueBase, switchable on the same display, even per radiologist.

Enabling visualization of both general radiology and mammography images, Nio Color 5MP eliminates the need for separate workstations. This leads to reductions in display cost, real estate and the operational expenditure required to maintain an enterprise-wide display fleet.

The Nio Color 5MP will be on display at the European Congress of Radiology (ECR), March 1-5 in Vienna, Austria.

Commercial availability in the U.S. is pending U.S. Food and Drug Administration (FDA) clearance.

For more information: www.barco.com

Related Content

Sponsored Content | Videos | Pediatric Imaging | February 22, 2018
FUJIFILM Medical Systems U.S.A., Inc. and FUJIFILM SonoSite Inc., are offering a full-suite pediatric solutions...
Sponsored Content | Videos | Flat Panel Displays | February 21, 2018
This 5 megapixel, high-brightness color monitor has the high-definition display necessary for breast imaging.
Barco Highlights Imaging Workflow Compliance at HIMSS18
News | Flat Panel Displays | February 21, 2018
Barco will showcase its full line of radiology and mammography display systems with online quality assurance (QA)...
DenseBreast-info.org Launches European-Focused Education Coalition
News | Breast Density | February 19, 2018
DenseBreast-info.org (DB-I) announced plans for international expansion with specialized content for Europe and...
A brain MRI. Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns.
Feature | Magnetic Resonance Imaging (MRI) | February 16, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Sponsored Content | Videos | Imaging | February 15, 2018
David Widmann, president and CEO of Konica Minolta, looks at what the future of healthcare can bring to its customers,...
Sponsored Content | Videos | Artificial Intelligence | February 15, 2018
ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence advances at the Radiological Soci
Videos | Enterprise Imaging | February 13, 2018
ITN Contributing Editor Greg Freiherr offers an overview of enterprise imaging advances at the Radiological Society of...
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
News | Women's Health | February 01, 2018
February 1, 2018 – Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to
Overlay Init